Group 1 - The company announced the early termination of the share reduction plan by shareholders and senior management [5] - Before the reduction plan, shareholder Gu Cuiyue held 1,342,800 shares (0.81% of total shares), while other key personnel held varying amounts [2] - The actual share reduction included Gu Cuiyue reducing 230,500 shares (0.14%), Vice President Shan Yongxiang reducing 313,000 shares (0.19%), and CFO Wu Hancun reducing 167,400 shares (0.10%) [3][4] Group 2 - The company signed a technical development contract with Tsinghua University for research on sodium-ion and solid-state lithium-ion battery electrolytes, with significant uncertainty regarding the outcomes [8][9] - The contract is in the early research phase and is not expected to impact the company's main business or 2025 financial performance significantly [8][10] - The main products of the company's subsidiary, Fengshan Quannuo, are sodium-ion and lithium-ion battery electrolytes, with limited revenue and intense market competition [10]

Core Viewpoint - The signing of the technology development contract with Tsinghua University is primarily for research purposes, with significant uncertainty regarding the development outcomes and their commercialization [1] Group 1: Company Impact - The technology development contract does not have an impact on the company's main business, which remains unchanged [1] - The company does not expect a significant impact on its operating performance for 2025 due to this contract [1] Group 2: Product and Market Context - The main products sold by the company's subsidiary, Fengshan Quannuo, are sodium-ion and lithium-ion battery electrolytes, which currently generate a small revenue scale [1] - The industry market for these products is highly competitive, and the company does not engage in revenue related to solid-state battery electrolyte materials [1]

| 证券代码：603810 | 证券简称：丰山集团 | 公告编号：2025-062 | | --- | --- | --- | | 转债代码：113649 | 转债简称：丰山转债 | | 江苏丰山集团股份有限公司 股东、董事兼高级管理人员提前终止减持计划暨减持 股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 股东及董事兼高级管理人员持股的基本情况 公司于 2025 年 6 月 17 日披露了《股东、董事兼高级管理人员减持股份计划 公告》（公告编号：2025-038）（以下简称"减持计划"）。2025 年 8 月 12 日 至 2025 年 9 月 17 日期间，股东顾翠月女士通过集中竞价方式减持公司股份 230,500 股，占公司总股本的 0.14%；公司董事、副总裁单永祥先生通过集中竞 价方式减持公司股份 313,000 股，占公司总股本的 0.19%；公司董事、财务总监 吴汉存先生通过集中竞价方式减持公司股份 167,400 股，占公司总股本的 0.10%。 | 股东名称 | 顾翠月 ...

| 证券代码：603810 | 证券简称：丰山集团 | 公告编号：2025-063 | | --- | --- | --- | | 转债代码：113649 | 转债简称：丰山转债 | | 关于签订《技术开发合同书》的补充暨风险提示公告 一、关于签署的《技术开发合同书》的补充说明 1、本协议为双方就钠离子电池电解液及固态锂离子电池用电解质进行课题 性开发的合作，合同金额较小。同时，目前合作处于初步研究开发阶段，本次技 术开发项目周期至 2028 年 12 月 31 日，后续研发成果及成果的商业化存在较大 的不确定性，对公司 2025 年业绩不产生影响。 2、目前，公司委托清华大学开发的产品及制备工艺技术指标要求较高，在 成本控制、匹配电池能量密度、电导率、实际工作场景需求等技术应用方面存在 一定难度，目前尚处于实验室研究阶段，具有较大的技术难度，开发进度及结果 具有较大不确定性。 江苏丰山集团股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次与清华大学签署的《技术开发合同书》仅为课题性研发，开发难 ...

Core Viewpoint - The signing of the "Technical Development Contract" with Tsinghua University is primarily for research purposes, with significant uncertainty regarding the development outcomes and their commercialization [1] Group 1: Company Impact - The technical development contract does not have an impact on the company's main business operations, which remain unchanged [1] - The company does not expect any significant effect on its operating performance for the year 2025 due to this contract [1] Group 2: Product and Market Context - The main products sold by the company's subsidiary, Fengshan Quannuo, are sodium-ion and lithium-ion battery electrolytes, which currently generate a small revenue scale [1] - The industry market for these products is highly competitive, and the company does not engage in revenue related to solid-state battery electrolyte materials [1]

Core Viewpoint - The signing of the supplementary announcement regarding the "Technical Development Contract" with Tsinghua University is primarily for research purposes, with significant uncertainty regarding the development outcomes and their commercialization [1] Company Summary - The technical development contract does not impact the company's main business, which remains unchanged and will not significantly affect the operating performance in 2025 [1] - The company's subsidiary, Fengshan Quannuo, currently has a small revenue scale from its main products, sodium-ion and lithium-ion battery electrolytes, in a highly competitive market [1] - The company does not engage in revenue related to solid-state battery electrolyte materials [1]

Group 1 - Honghe Technology plans to increase capital by 300 million yuan to its wholly-owned subsidiary Huangshi Honghe through debt-to-equity conversion, raising its registered capital from 700 million yuan to 1 billion yuan [1] - Huaxia Happiness has completed debt restructuring amounting to approximately 192.67 billion yuan, with a total of 24 billion yuan in overdue debts as of August 31 [1] - Chengyi Pharmaceutical's controlling shareholder plans to reduce its stake by up to 1.18%, amounting to 387,560 shares [1][2] Group 2 - Yuanwang Valley received a warning letter from the Shenzhen Securities Regulatory Bureau for failing to halt trading when its controlling shareholder's stake changed to a multiple of 5% [2] - Gongjin Co. received government subsidies of 8.9 million yuan, accounting for 11.13% of its latest audited net profit [3] - Maiwei Biotech's application for the listing of 9MW0813 injection has been accepted by the National Medical Products Administration [4] Group 3 - Jianfeng Group plans to repurchase shares worth between 20 million and 40 million yuan at a maximum price of 12.42 yuan per share [6] - Ankai Micro plans to invest 20 million yuan to acquire a 4% stake in Shiqi Future [7] - Pinming Technology's stock will continue to be suspended as it is actively pursuing a significant matter that may lead to a change in control [8] Group 4 - China Communications has signed new contracts worth 256.34 billion yuan from January to August, with domestic contracts totaling 206.05 billion yuan [18] - Round Express reported a revenue of 5.39 billion yuan in August, a year-on-year increase of 9.82% [38] - China Pacific Insurance's original insurance premium income reached 217.05 billion yuan from January to August, up 13.2% year-on-year [39] Group 5 - *ST Chuangxing's chairman is under investigation, and the general manager will act as the chairman during this period [40] - Fengshan Group signed a technical development contract with Tsinghua University for a project related to sodium-ion battery electrolytes [40] - Yongxin Optical stated that its optical components related to lithography machines account for less than 1% of its revenue [41] Group 6 - Tianyuan Dike's subsidiary received a government subsidy of 3.77 million yuan, representing 16.27% of its latest audited net profit [42] - Huaxiang Co. plans to issue convertible bonds to raise no more than 1.308 billion yuan for various projects [43] - Wolong Electric Drive reported that its robot-related products accounted for only 2.71% of total revenue in the first half of the year [44]

Market Overview - The agricultural chemical sector rose by 0.87% on September 19, with Fengshan Group leading the gains [1] - The Shanghai Composite Index closed at 3820.09, down 0.3%, while the Shenzhen Component Index closed at 13070.86, down 0.04% [1] Top Performers - Fengshan Group (603810) closed at 16.03, up 10.02% with a trading volume of 59,000 shares and a transaction value of 94.08 million yuan [1] - Baiao Chemical (603360) closed at 26.93, up 5.90% with a trading volume of 344,500 shares and a transaction value of 918 million yuan [1] - Hongda Co., Ltd. (600331) closed at 11.43, up 4.00% with a trading volume of 609,300 shares [1] Underperformers - Jinzengda (002470) closed at 1.84, down 4.66% with a trading volume of 1,317,300 shares [2] - Chitianhua (600227) closed at 2.53, down 4.17% with a trading volume of 333,100 shares [2] - Meibang Co., Ltd. (605033) closed at 22.60, down 3.87% with a trading volume of 45,900 shares [2] Capital Flow - The agricultural chemical sector experienced a net outflow of 134 million yuan from institutional investors, while retail investors saw a net inflow of 119 million yuan [2][3] - The main capital inflow and outflow for key stocks in the sector were detailed, with Hongda Co., Ltd. seeing a net inflow of 74.23 million yuan from institutional investors [3]

| 证券代码：603810 | 证券简称：丰山集团 | 公告编号：2025-061 | | --- | --- | --- | | 转债代码：113649 | 转债简称：丰山转债 | | 江苏丰山集团股份有限公司 关于使用部分闲置募集资金进行现金管理到期赎回的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 江苏丰山集团股份有限公司（以下简称"公司"）于 2025 年 4 月 28 日召开 第四届董事会第十一次会议和第四届监事会第七次会议，于 2025 年 5 月 19 日召 开 2024 年年度股东大会审议通过了《关于 2025 年度公司使用闲置募集资金和自 有资金在非关联方机构进行现金管理的议案》，同意在确保不影响公司募投项目 建设、主营业务的正常开展、日常运营资金周转需要和资金安全的前提下，使用 不超过人民币 30,000 万元的公开发行可转换公司债券闲置募集资金进行现金管 理，用于投资安全性高、流动性好、发行主体有保本约定、单项产品期限最长不 超过十二个月的各种存款、理财产品或中国证监会认可的其他投资品种等（包括 ...

Core Viewpoint - Jiangsu Fengshan Group Co., Ltd. has approved the use of up to 300 million yuan of idle funds from the public offering of convertible bonds for cash management, with a validity period of 12 months [1] Group 1 - The company disclosed information regarding the special settlement account for cash management products related to the raised funds [1] - On September 19, 2025, the company redeemed a structured deposit of 40 million yuan from Citic Bank Yancheng Dafeng Branch, with a principal redemption of 40 million yuan and earnings of 171,400 yuan [1] - As of the announcement date, the company has 200 million yuan in cash management that has not yet matured, which is within the authorized range of the board of directors [1]